Gregory P. Hanson is CFO at MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX). They have made 8 open-market trades across 2 companies since 2006, most recently 2018-04-02.
CIK 0001186120
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
3 open-market purchases totalling $26K since 2006, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MBVX | SELL | 2018-01-16 | 2018-01-18 | $0.92 | $39K | -16.2% | -6.6% | -42.6% |
| MBVX | SELL | 2018-01-10 | 2018-01-16 | $0.97 | $113K | -14.5% | -25.5% | -46.8% |
| MBVX | BUY | 2017-05-19 | 2017-08-02 | $1.75 | $8K | -21.4% | -37.1% | -11.4% |
| MBVX | SELL | 2017-04-12 | 2017-04-14 | $2.00 | $8K | +7.2% | +3.0% | -49.7% |
| MBVX | SELL | 2017-04-07 | 2017-04-11 | $2.00 | $2K | +5.8% | -1.1% | -45.8% |
| MBVX | SELL | 2017-04-04 | 2017-04-06 | $2.18 | $8K | -6.9% | -4.9% | -37.4% |
| MBVX | BUY | 2014-12-16 | 2014-12-17 | $2.50 | $8K | +4.5% | -4.8% | -4.8% |
| AVNR | BUY | 2006-05-26 | 2006-05-26 | $9.67 | $11K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.